SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?


To: skinowski who wrote (148790)11/26/2005 11:39:54 AM
From: Lane3  Read Replies (1) | Respond to of 793955
 
Generally, I think that Medicare Part "D" - the drug coverage plan - could have been designed to have a much lower price tag.

What do you have in mind?



To: skinowski who wrote (148790)11/26/2005 2:04:30 PM
From: LindyBill  Read Replies (1) | Respond to of 793955
 
I see that "donut hole" being closed by Medicare HMO plans. Maybe that was the design - to get HMO's to contribute.

When I got my 06 manual from Kaiser, they started by explaining their personal plan. The doughnut hole blew my mind. Then my medicare section was extremely simple. $10 copay for a generic, $40 for a brand, no deductable. So it is obviously designed for an HMO. Which is fine, we need to get rid of single coverage or it will take over the entire budget.

I will have an interesting case with my only expensive drug, the weight reduction one, Orlistat. I paid $145 for the last 30 day prescription, and was going to give it up. Now it looks like I will get a 90 day supply for a double co-pay of $80 by using mail order. That's under $27 for a 30 day supply, a saving of $118 a month. At that price, I will stay on it.